» Articles » PMID: 16952850

Dermatofibrosarcoma Protuberans: Review of 20-years Experience

Overview
Specialty Oncology
Date 2006 Sep 6
PMID 16952850
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Dermatofibrosarcoma protuberans (DFSP) is an uncommon soft tissue neoplasm with low-intermediate grade of malignancy. It is a locally aggressive tumour with a high recurrence rate. Surgical excision with adequate margins is the main treatment.

Materials And Methods: We describe the clinicopathological features of 21 cases of DFSP. The mean size of the lesions was 5.6 cm, mostly located in trunk. 61.9% of the cases underwent surgical excision without previous biopsy. 52.4% of the patients presented positive margins, that required surgical extension.

Results: The recurrence rate was 28.6% (6 cases), five of them local recurrences treated with new surgical excision with wide margins. Median period free of illness was 32.5 months. Medium follow-up period was 33.25 months.

Conclusions: DFSP has a locally high recurrence rate, that has been associated to inadequate surgical margins. The histological knowledge preoperatively would permit surgical excision with adequate margins, and probably this could reduce the recurrence rate. Radiotherapy could avoid the surgical extension of margins in these cases with positive ones. Chemotherapy could be indicated in metastasic cases. Most recurrences appear in the first 3 years, but it is important a long-term follow-up of these patients.

Citing Articles

Management of Forehead Dermatofibrosarcoma Protuberans With Wide Local Excision and Paramedian Forehead Flap Reconstruction: A Case Report.

Irshad A, Akram M, Ijaz S, Rehman A, Khalid A, Iftikhar M Cureus. 2025; 16(12):e76322.

PMID: 39850162 PMC: 11756705. DOI: 10.7759/cureus.76322.


Recurrent Dermatofibrosarcoma Protuberance: A Case Report.

Shah S, Regmee S, Maharjan D, Thapa P JNMA J Nepal Med Assoc. 2022; 59(243):1192-1195.

PMID: 35199742 PMC: 9124319. DOI: 10.31729/jnma.7187.


Resection and Reconstructive Options in the Management of Dermatofibrosarcoma Protuberans of the Head and Neck.

Akhtar A, Khan A, Rashid M, Eitezaz F, Rashid H Cureus. 2020; 12(7):e9423.

PMID: 32864249 PMC: 7450883. DOI: 10.7759/cureus.9423.


Dermatofibrosarcoma Protuberans of the Breast-a Rare Entity.

Maji S, Paul M, Sen S Indian J Surg Oncol. 2018; 9(3):351-354.

PMID: 30287997 PMC: 6154368. DOI: 10.1007/s13193-017-0684-8.


Induction of antitumor response to fibrosarcoma by Newcastle disease virus-infected tumor vaccine.

Takamura-Ishii M, Miura T, Nakaya T, Hagiwara K Med Oncol. 2017; 34(10):171.

PMID: 28864944 PMC: 5581369. DOI: 10.1007/s12032-017-1034-y.


References
1.
Bowne W, Antonescu C, Leung D, Katz S, Hawkins W, Woodruff J . Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution. Cancer. 2000; 88(12):2711-20. View

2.
Labropoulos S, Fletcher J, Oliveira A, Papadopoulos S, Razis E . Sustained complete remission of metastatic dermatofibrosarcoma protuberans with imatinib mesylate. Anticancer Drugs. 2005; 16(4):461-6. DOI: 10.1097/00001813-200504000-00014. View

3.
Mendenhall W, Zlotecki R, Scarborough M . Dermatofibrosarcoma protuberans. Cancer. 2004; 101(11):2503-8. DOI: 10.1002/cncr.20678. View

4.
Lindner N, Scarborough M, Powell G, Spanier S, ENNEKING W . Revision surgery in dermatofibrosarcoma protuberans of the trunk and extremities. Eur J Surg Oncol. 1999; 25(4):392-7. DOI: 10.1053/ejso.1999.0663. View

5.
Rutgers E, Kroon B, Gortzak E . Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol. 1992; 18(3):241-8. View